Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus (Q44849906)

6 December 2017

Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus (English)

1 reference

6 December 2017

1 reference

1 reference

1 reference

Shosaku Nomura

1

1 reference

6 December 2017

Akira Shouzu

2

1 reference

6 December 2017

Seitaro Omoto

3

1 reference

6 December 2017

Mitsushige Nishikawa

4

1 reference

6 December 2017

Toshiji Iwasaka

5

1 reference

6 December 2017

1 April 2004

1 reference

Clinical and Applied Thrombosis-Hemostasis

6 December 2017

1 reference

6 December 2017

10

1 reference

6 December 2017

2

1 reference

6 December 2017

133-141

1 reference

Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

6 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Immune mechanisms of atherosclerosis in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Current concepts: immunology. Monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Procoagulant and profibrinolytic activities of cryopreserved human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

NIDDM is the Major Cause of Diabetic End-Stage Renal Disease: More Evidence From a Tri-Ethnic Community

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Microalbuminuria and coronary heart disease in NIDDM: an incidence study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Progression, remission, regression of chronic renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Losartan in patients with type 2 diabetes and proteinuria: observations from the RENAAL Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Effect of losartan in aging-related endothelial impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Endothelial-leukocyte adhesion molecules in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Leucocyte-endothelial interactions and regulation of leucocyte migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Statins as potent antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Simvastatin reduces plasma concentration of high-sensitivity C-reactive protein in type 2 diabetic patients with hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Effect of combining ACE inhibitor and statin in severe experimental nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

Inhibition of tissue-factor-mediated thrombin generation by simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000203

10.1177/107602960401000203

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference